Govt's draft National Pharma Pricing Policy find few takers

The government's aim to regulate prices of all 348 essential drugs in the country is not going well with the Indian pharma industry.

November 01, 2011 / 09:15 IST

26 Aug, 2025 12:21

Volume

Todays L/H

The government's aim to regulate prices of all 348 essential drugs in the country is not going well with the Indian pharma industry. CNBC-TV18's Archana Shukla gets us reactions to the draft National Pharmaceutical Pricing Policy, 2011.

Ten years in the works... and finally, has the government's draft Pharma Pricing Policy been able to strike the right balance between looking after consumer health and industry wealth? Well, does not seem so...with majority drug firms opposing government control of all essential medicine prices saying it will limit the sector's growth

Kewal Handa, MD of Pfizer India said it is going beyond the NLEM list and beyond SC order.

first published: Oct 31, 2011 09:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347